MULTICENTER OBSERVATORY EVALUATING THE POLYMER-FREE SIROLIMUS ELUTING CORONARY STENT SYSTEM VIVO ISAR IN ROUTINE CLINICAL PRACTICE - Trial NCT06420505
Access comprehensive clinical trial information for NCT06420505 through Pure Global AI's free database. This phase not specified trial is sponsored by Translumina GmbH and is currently Recruiting. The study focuses on Artery Coronary Stenosis. Target enrollment is 3000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Translumina GmbH
Timeline & Enrollment
N/A
Nov 29, 2023
Jan 01, 2027
Primary Outcome
rate of target lesion failure
Summary
The rationale for this observatory is to evaluate clinical outcomes and collect data of the
 Polymer Free Sirolimus Eluting Coronary Stent System in Real World CAD Patients with
 follow-up at 12 months. All medications and procedures to be used/ performed in this
 observatory are commonly used/performed for clinical indications as part of standard of care
 and have well-defined safety profiles.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06420505
Device Trial

